Can the health emergency of COVID-19 have a long-term impact on a company’s value? Can companies engaged in acquisition operations use the Material Adverse Change (MAC) / Material Adverse Events (MAE) clauses as an exit strategy for mitigating investment costs or terminating agreements? Very current questions. Here are some thoughts from experts, including our Andrea Marchetti. Article by Carlotta Scozzari (Business Insider Italia).